Categories Earnings, Leisure & Entertainment

A visual dashboard of Take-Two Interactive Software (TTWO) Q4 2020 earnings results

Take-Two Interactive Software’s (NASDAQ: TTWO) income more than doubled in the fourth quarter of 2020 compared to the prior-year quarter. Earnings on a GAAP basis, stood at $1.07 per share compared to $0.50 per share in Q4 2019. Revenue grew 41% to $760.5 million. Net bookings increased by 49% to $729.4 million. TTWO stock rose about 4% immediately after the earnings announcement and later turned into the negative territory.

Take-Two Interactive Software (TTWO) Q4 2020 earnings infograph

For fiscal 2021, Take-Two Interactive Software expects GAAP EPS to be between $2.60 and $2.85 and GAAP revenue to be in the range of $2.63 billion to $2.73 billion. Net bookings are expected to range from $2.55 billion to $2.65 billion.

For the first quarter of 2021, the gaming firm expects GAAP EPS to be between $0.90 and $1.00 and GAAP revenue to be in the range of $775 million to $825 million. Net bookings are expected to range from $800 million to $850 million.

TTWO stock, which surged to a new 52-week high ($149.28) today, had gained 20% since the beginning of this year.

Most Popular

Here’s a look at Dollar Tree’s (DLTR) expectations for the remainder of the year

Shares of Dollar Tree Inc. (NASDAQ: DLTR) were down over 1% on Wednesday, a day after the company reported earnings results for the third quarter of 2022. Revenue and earnings

Target Corporation (TGT): A look at how the retail giant is shaping up against an inflationary backdrop

Shares of Target Corporation (NYSE: TGT) were up over 1% on Wednesday. The stock has dropped 30% year-to-date and 35% over the past 12 months. Last week the company reported

Is Zoom Video Communications (ZM) a good investment after Q3 earnings?

Zoom Video Communications (NASDAQ: ZM) expanded its customer base at an accelerated pace during the COVID crisis and soon became the preferred video conferencing platform for businesses and millions of

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top